The UK's National Health Service is cutting costs by rationing A fifth of new medicines and campaigners have warned that this will put patients' safety at risk as well as making them suffer longer delays for medication. Furthermore, pharmaceutical companies have said they will no longer launch drugs early in the UK if health chiefs are given the power to stop them getting to patients because of financial concerns. This move could put the country further behind other nations in offering the latest drugs and therapies.
The UK's National Health Service is cutting costs by rationing a fifth of new medicines and campaigners have warned that this will put patients' safety at risk as well as making them suffer longer delays for medication. Furthermore, pharmaceutical companies have said they will no longer launch drugs early in the UK if health chiefs are given the power to stop them getting to patients because of financial concerns. This move could put the country further behind other nations in offering the latest drugs and therapies.